Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001267602-23-000031
Filing Date
2023-05-01
Accepted
2023-05-01 17:25:47
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alim-20221231x10ka.htm   iXBRL 10-K/A 1221926
2 EX-31.1 alim-20221231xex31_1.htm EX-31.1 13910
3 EX-31.2 alim-20221231xex31_2.htm EX-31.2 13614
  Complete submission text file 0001267602-23-000031.txt   1512200

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20221231.xsd EX-101.SCH 2156
5 EX-101.LAB alim-20221231_lab.xml EX-101.LAB 29769
6 EX-101.PRE alim-20221231_pre.xml EX-101.PRE 17674
8 EXTRACTED XBRL INSTANCE DOCUMENT alim-20221231x10ka_htm.xml XML 8075
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

EIN.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34703 | Film No.: 23875328
SIC: 2834 Pharmaceutical Preparations